# Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer

> clinical trial · VERIFIED · 2026-08-04

Status: NOT_YET_RECRUITING · Sponsor: Ruijin Hospital · Condition: Pancreatic Ductal Adenocarcinoma

- Company: Ruijin Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07745790

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
